Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
142 | 4079 | 44.4 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
705 | 12205 | MATRIX METALLOPROTEINASES//CD147//MATRIX METALLOPROTEINASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MT1 MMP | Author keyword | 90 | 46% | 4% | 146 |
2 | CANC CELL | Address | 48 | 46% | 2% | 77 |
3 | MMP 2 | Author keyword | 42 | 19% | 5% | 205 |
4 | MATRIX METALLOPROTEINASES | Author keyword | 42 | 11% | 9% | 362 |
5 | TIMP 2 | Author keyword | 34 | 31% | 2% | 94 |
6 | MMP 7 | Author keyword | 32 | 39% | 2% | 64 |
7 | MT MMP | Author keyword | 31 | 71% | 1% | 25 |
8 | MATRILYSIN | Author keyword | 29 | 41% | 1% | 55 |
9 | GELATINASE A | Author keyword | 28 | 39% | 1% | 57 |
10 | STROMELYSIN 3 | Author keyword | 26 | 57% | 1% | 31 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MT1 MMP | 90 | 46% | 4% | 146 | Search MT1+MMP | Search MT1+MMP |
2 | MMP 2 | 42 | 19% | 5% | 205 | Search MMP+2 | Search MMP+2 |
3 | MATRIX METALLOPROTEINASES | 42 | 11% | 9% | 362 | Search MATRIX+METALLOPROTEINASES | Search MATRIX+METALLOPROTEINASES |
4 | TIMP 2 | 34 | 31% | 2% | 94 | Search TIMP+2 | Search TIMP+2 |
5 | MMP 7 | 32 | 39% | 2% | 64 | Search MMP+7 | Search MMP+7 |
6 | MT MMP | 31 | 71% | 1% | 25 | Search MT+MMP | Search MT+MMP |
7 | MATRILYSIN | 29 | 41% | 1% | 55 | Search MATRILYSIN | Search MATRILYSIN |
8 | GELATINASE A | 28 | 39% | 1% | 57 | Search GELATINASE+A | Search GELATINASE+A |
9 | STROMELYSIN 3 | 26 | 57% | 1% | 31 | Search STROMELYSIN+3 | Search STROMELYSIN+3 |
10 | MMP 9 | 26 | 12% | 5% | 204 | Search MMP+9 | Search MMP+9 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IV COLLAGENASE | 402 | 35% | 23% | 937 |
2 | TISSUE INHIBITOR | 192 | 17% | 25% | 1008 |
3 | PROGELATINASE A | 151 | 58% | 4% | 174 |
4 | GELATINASE A | 142 | 34% | 9% | 347 |
5 | MT MMP | 118 | 81% | 2% | 70 |
6 | MT1 MMP | 110 | 48% | 4% | 168 |
7 | TIMP 2 | 100 | 45% | 4% | 165 |
8 | 1 MATRIX METALLOPROTEINASE | 89 | 52% | 3% | 123 |
9 | MR 72 000 | 66 | 83% | 1% | 38 |
10 | TUMOR INVASION | 59 | 18% | 7% | 293 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
New functions for the matrix metalloproteinases in cancer progression | 2002 | 2948 | 139 | 49% |
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment | 2010 | 988 | 127 | 28% |
Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets | 2013 | 66 | 124 | 70% |
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations | 2002 | 1482 | 42 | 71% |
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry | 2003 | 2013 | 154 | 34% |
Matrix metalloproteinases and tumor metastasis | 2006 | 824 | 218 | 54% |
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression | 2012 | 125 | 107 | 47% |
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting | 2011 | 278 | 82 | 38% |
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer | 2009 | 287 | 139 | 49% |
How matrix metalloproteinases regulate cell behavior | 2001 | 1988 | 210 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC CELL | 48 | 46% | 1.9% | 77 |
2 | MOL ONCOL VIROL | 9 | 29% | 0.6% | 25 |
3 | RECEPTOR BIOL TUMOR METASTASIS | 8 | 44% | 0.3% | 14 |
4 | MMP UNIT | 6 | 100% | 0.1% | 4 |
5 | S ARTHUR LOCALIO SURG | 6 | 100% | 0.1% | 4 |
6 | MOL VIROL ONCOL | 5 | 18% | 0.6% | 25 |
7 | TUMOR DEV BIOL | 4 | 15% | 0.7% | 27 |
8 | CLIN ONCOL CHAIR | 4 | 75% | 0.1% | 3 |
9 | DERMATOL CLIN BIOL EXTRACELLULAR MATRIX F7 | 4 | 75% | 0.1% | 3 |
10 | MATRIX METALLOPROTEINASE UNIT | 4 | 41% | 0.2% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000275844 | TIMP 1//SORSBYS FUNDUS DYSTROPHY//SORSBY FUNDUS DYSTROPHY |
2 | 0.0000204794 | TUMOR TISSUE PROGRESSION//FIBROBLAST COLLAGENASE//CARRAGEENAN GRANULOMA |
3 | 0.0000140832 | TACE INHIBITORS//TACE INHIBITOR//MMP INHIBITORS |
4 | 0.0000127003 | RECK//REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS//KINOME PROFILING UNIT |
5 | 0.0000121741 | MODIFIED TETRACYCLINE//IMPERIAL WELLCOME TRUST CLIN TROP MED//MAZANKOWSKI ALBERTA HEART PHARMACOL |
6 | 0.0000105134 | MORPHOL ESTOMATOL PHYSIOL//2K 1C HYPERTENSION//MED IPB HSL |
7 | 0.0000094901 | SB 3CT//HEAD SHAKE RESPONSE//BBB BREAKDOWN |
8 | 0.0000071284 | KANEMATSU//ISOLATED GLOMERULI//NEPHROL A |
9 | 0.0000065121 | CD147//EMMPRIN//EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER |
10 | 0.0000063691 | NUTRIENT MIXTURE//MATRIGEL INVASION//PLANT POLYPHENOL EXTRACT |